Stay updated on G1T48 Alone & With Palbociclib in ER+ Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the G1T48 Alone & With Palbociclib in ER+ Advanced Breast Cancer Clinical Trial page.

Latest updates to the G1T48 Alone & With Palbociclib in ER+ Advanced Breast Cancer Clinical Trial page
- Check3 days agoChange DetectedThe page now displays the ClinicalTrials.gov record for the G1T48 breast cancer study, with its study design, participant criteria, locations, and outcome measures.SummaryDifference59%

- Check10 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoChange DetectedAn NIH-wide banner announces a transition in terminology, saying some content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).SummaryDifference1%

- Check24 days agoChange DetectedThe footer now displays site revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check31 days agoChange DetectedThe footer revision label updates from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check45 days agoChange DetectedThe study record page now shows a 403 Forbidden error page. The page chrome remains visible, but access to the content is blocked.SummaryDifference0.5%

Stay in the know with updates to G1T48 Alone & With Palbociclib in ER+ Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the G1T48 Alone & With Palbociclib in ER+ Advanced Breast Cancer Clinical Trial page.